Heart disease is the No. 1 killer among men and women in the U.S. Nearly half of all adults with premature coronary artery disease are missed by standard lipid profiles.

Genova Diagnostics is proud to introduce CV Health Plus Genomics, the most comprehensive view of cardiovascular health. Identifying genetic risk factors related to cardiovascular disease and utilizing technology newly approved by the FDA, this test integrates clinically relevant information, such as standard cardio markers long with innovative new markers. Genova Diagnostics is also introducing CV Health without the genomics aspect of the test.

Better Tests. Better Health. Better Life! That's what Genova Diagnostics is all about.